Midwest Allergy Sinus Asthma is a clinical research site located in Normal, Illinois, United States 61761.
Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.
Midwest Allergy Sinus Asthma has participated in 3 clinical trials with 1 currently active.
Therapeutic areas: Chronic Rhinosinusitis, Eosinophilic Asthma, Clonal Mast Cell Disease.
Sponsors: Optinose US Inc., AnaptysBio, Inc., Blueprint Medicines Corporation.
Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Midwest Allergy Sinus Asthma has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Midwest Allergy Sinus Asthma has 3 clinical trials on record, with 1 currently active. Their work covers Chronic Rhinosinusitis, Eosinophilic Asthma, Clonal Mast Cell Disease.
Midwest Allergy Sinus Asthma has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.